TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Clinical trial NCT00540449 · COMPLETED

Trial details

NCT number: NCT00540449
Sponsor: Tibotec Pharmaceuticals, Ireland
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Infections HIV-1 Human Immunodeficiency Virus Type 1

Start date: 2008-05-01
Primary completion: 2010-02-01
Enrollment: 694

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.